| Purpose | Patients | Evaluations | Perceived Effectiveness |
|---|---|---|---|
| Systemic lupus erythematosus | 1,445 | 15 | |
| Multiple sclerosis | 609 | 361 | |
| Chronic obstructive pulmonary disease | 403 | 7 | |
| Prevent organ rejection | 220 | 18 | |
| Optic neuritis | 92 | 28 |
Common side effects
| Side effect | Patients | Percentage |
|---|---|---|
| Insomnia | 78 | |
| Metallic taste in mouth | 71 | |
| Weight gain | 61 | |
| Increased appetite | 46 | |
| Change in taste | 39 | |
| Headaches | 39 |
Side effect severity
| Severity | Evaluations | Percentage |
|---|---|---|
| Severe | 143 | |
| Moderate | 301 | |
| Mild | 270 | |
| None | 213 |
Member evaluations
GPS
evaluated on Jan 27, 2010
- Perceived effectiveness for multiple sclerosis: Moderate
- Side effects: Mild
Zach Underwood
evaluated on Feb 12, 2010
- Perceived effectiveness for vertigo: Major
- Side effects: Mild
Zach Underwood
evaluated on Jan 31, 2010
- Perceived effectiveness for vertigo: Moderate
- Side effects: None